发明名称 |
Flagellin fusion proteins |
摘要 |
Methods of making a protein that stimulates a protective immune response in a subject include separating a portion of a protein from a naturally occurring influenza viral hemagglutinin to form a protein portion. |
申请公布号 |
US9200042(B2) |
申请公布日期 |
2015.12.01 |
申请号 |
US201414565735 |
申请日期 |
2014.12.10 |
申请人 |
VaxInnate Corporation |
发明人 |
Song Langzhou;Nakaar Valerian;Price Albert E.;Tussey Lynda G.;Huleatt James W.;Powell Thomas J.;Evans Robert K. |
分类号 |
C12N15/62;C07K14/11;A61K39/02;A61K39/108;A61K39/12;A61K39/145;A61K39/385;C07K14/005;C07K14/195;C07K14/255;C12N7/00;A61K39/00 |
主分类号 |
C12N15/62 |
代理机构 |
Hamilton, Brook, Smith & Reynolds, P.C. |
代理人 |
Hamilton, Brook, Smith & Reynolds, P.C. |
主权项 |
1. A method of making an immunogenic fusion protein, comprising the steps of:
a) transforming a nucleic acid encoding a fusion protein into a prokaryotic host cell, the fusion protein including,
i) at least a portion of a flagellin that initiates an intracellular signal transduction pathway for a Toll-like Receptor, andii) a portion of an influenza viral hemagglutinin, wherein the portion of the influenza viral hemagglutinin lacks
a transmembrane domain; anda cytoplasmic domain, and includes, at least a portion of a globular head; and at least a portion of at least one secondary structure having at least one β-sheet at a bottom of the globular head that causes the globular head to essentially retain its tertiary structure; and b) culturing the prokaryotic host cell to thereby make the immunogenic fusion protein. |
地址 |
Cranbury NJ US |